Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?

Autor: Houpu Yang, Lixin Zhou, Shu Wang, Yingming Cao, Fuzhong Tong, Peng Liu, Bo Zhou, Lin Cheng, Miao Liu, Hongjun Liu, Fei Xie, MDa, Jiajia Guo, Siyuan Wang, Yuan Peng, Yang, Houpu, Zhou, Lixin, Wang, Shu, Cao, Yingming, Tong, Fuzhong
Zdroj: Medicine; Oct2018, Vol. 97 Issue 40, p1-8, 8p
Databáze: Complementary Index